Infrastructure Investment Plan 2021-22 to 2025-26: major capital projects progress update - August 2025

Sector: Health

Project: NHS Ayrshire & Arran - Foxgrove (National Secure Adolescent Inpatient Service)

Business case approved stages: Project comprises 12 bedded medium secure adolescent inpatient facility for Scotland located in Irvine, North Ayrshire . The Full Business Case (FBC) outlined that the estimated cost of project was £18.7 million and that it would be operational by December 2023 (Frameworks Scotland is procurement route for project).

Progress at February 2025: As previously reported, the project has been delayed due to key risks relating to completion of defects.

Weekly project meetings are scheduled with the Principal Supply Chain Partner (PSCP) on site and separate weekly meetings are scheduled with key stakeholders to monitor progress. The Scottish Government are deploying additional monitoring resource to provide direct oversight of resolution of the issues.

The Scottish Government has also approved additional works to resolve the defects. It is now expected that completion of the build will be achieved in August 2025, with patients being admitted shortly thereafter. Final cost will be confirmed following completion (as reported in the August 2024 update, previous reports estimated the cost at £18.9 million, however additional costs are being incurred due to prolongation and programme delay).

Progress at August 2025: As previously reported, the project has been delayed due to key risks relating to completion of defects and the Scottish Government has approved additional works to resolve the defects.

The completion date will now be later than had been anticipated at the last update (August 2025) due to the number and complexity of defects to be resolved. A completion date is not confirmed at this time and final costs will be confirmed following completion.

Contact for public enquiries: email: fraser.bell@aapct.scot.nhs.uk

Project: NHS Grampian – Aberdeen Baird Family Hospital and ANCHOR Centre

Business case approved stages: Baird Family Hospital will provide a new facility to support maternity, gynaecology, breast screening and breast surgery services. It will also include a Neonatal Unit (NNU), accommodation for reproductive services, an operating theatre suite, a Community Maternity Unit (CMU), and research and teaching facilities. ANCHOR centre will be connected to the existing Radiotherapy Centre and together the single facility will provide a focus for all ambulatory care for oncology, haematology, and radiotherapy services in the north. The Outline Business Case (OBC) outlined a cost of £163.7 million and indicated that the ANCHOR Centre was projected to be operational in 2021 and the Baird to be handed over in 2021 and be fully operational early 2022. The Full Business Case (FBC) outlined that the total project cost was £233.2 million as per FBC Addendum and that the operational date for the ANCHOR Centre was estimated for May 2023 with the Baird Family Hospital estimated for December 2023 (Frameworks Scotland is procurement route for project).

Progress at February 2025: No change to cost since the last report (as reported in the March 2023 update, the cost was £261.1 million and the estimated operational date for the ANCHOR Centre was October 2023 with the Baird Family Hospital being September 2024).

Design reviews have recently concluded and a way forward has been agreed. Work is underway to implement several changes resulting from the design reviews and to understand the impact on cost and the timing of the programme.

Progress at August 2025: No change to cost since last report.

Work is continuing to implement several changes resulting from the design reviews and to understand the impact on cost and the timing of the programme.

Contact for public enquiries: email: gram.nhsgrampianfeedback@nhs.scot

Project: NHS Forth Valley - National Treatment Centre

Business case approved stages: Project to increase Elective Care capacity was scheduled to be completed by end of 2022. The investment case was approved through the Scottish Government in 2019. Revenue costs around £9 million with capital costs around £10 million subject to final confirmation (forms part of the National Treatment Centres Programme).

Progress at February 2025: No change to cost since last report (as reported in the September 2022 update, the capital costs were confirmed as £11.1 million).

The new ward continues to be delayed and an opening date is not yet confirmed for that ward (as reported in the December 2023 update, the estimated completion was anticipated in 2024 but there was no confirmed date). Work to agree a route to completion is ongoing. However, existing theatres (previously unused) have already been commissioned and in a phased opening, the National Treatment Centre began treating patients in October 2024.

Progress at August 2025: No change to cost since last report.

The new ward continues to be delayed and an opening date is not yet confirmed for that ward. Work to agree a route to completion is ongoing. As previously reported, existing theatres (previously unused) have already been commissioned and, in a phased opening, the National Treatment Centre began treating patients in October 2024.

Contact for public enquiries: email: scott.urquhart@nhs.scot

Project: NHS Greater Glasgow and Clyde - Radionuclide Dispensary

Business case approved stages: Project to create a modern Radiopharmacy facility to continue the manufacture of radiopharmaceutical medicines and distribution of them to Nuclear Medicine Departments throughout Health Boards in West Central Scotland and the West of Scotland. The Outline Business Case (OBC) outlined a cost of £20.9 million and that the project was to be operational July 2025. The Full Business Case (FBC) outlines a cost of £21.4 million and that the project will be operational by May 2026 (Hub West Scotland replaced Frameworks Scotland as procurement route for the project following OBC approval).

Progress at February 2025: No change to cost or timing since last report.

The FBC was approved in October 2024 and the project is now in construction. The forecast cost of the project is £21.4 million with a planned completion of May 2026.

Progress at August 2025: No change to FBC cost or timing since last report.

Contact for public enquiries: email: andrew.baillie@ggc.scot.nhs.uk

Project: NHS Lanarkshire - Monklands Replacement Project

Business case approved stages: Project will provide a replacement for the existing University Hospital Monklands in North Lanarkshire. The Outline Business Case (OBC) was approved in July 2023 outlining an estimated cost of £1.344 billion and a planned operational date of 2031.

Progress at February 2025: The Full Business Case (FBC) development continues and is expected to be submitted to the Scottish Government in early 2026. Cost estimates are being developed and the expected operational date will be included in the FBC.

Progress at August 2025: The FBC development continues and is expected to be submitted to the Scottish Government in 2026. Timing is dependent on receiving a supported status following the NHSScotland Design Assessment Process (NDAP) and the Key Stage Assurance Review (KSAR). Cost estimates are being developed and the expected operational date will be included in the FBC.

Contact for public enquiries: email: graeme.reid2@lanarkshire.scot.nhs.uk

Project: NHS Lothian - Reprovision of Eye Services

Business case approved stages: Project to re-provide eye services including those currently being delivered from the Princess Alexandra Eye Pavilion, Edinburgh (forms part of the National Treatment Centres Programme). The Outline Business Case (OBC) outlined that the total project cost is £112.5 million and that project is anticipated to be operational by December 2026 (Frameworks Scotland is procurement route for project).

Progress at February 2025: The 2025-26 Scottish Budget commits to progressing the work to replace the Princess Alexandra Eye Pavilion in Edinburgh and NHS Lothian is currently remobilising project team resources in order to take the project forward (this follows the previous pausing of the business case as reported in the December 2023 update as was common with all health capital investment projects in development until the necessary capital funding to complete them became available).

Progress at August 2025: NHS Lothian has been asked to progress the business case, including development of the design and timeline.

Contact for public enquiries: email: Lothian.Communications@nhslothian.scot.nhs.uk